ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Republican U.S. Tax Bill Deals Biggest Blow Yet to Obamacare

Yasmeen Abutaleb  |  December 20, 2017

WASHINGTON (Reuters)—Republicans delivered their biggest blow yet to Obamacare in their tax overhaul that won final congressional approval on Wednesday, and delayed until 2018 consideration of legislation that could help mitigate some of the damage to the 2010 law. The $1.5 trillion tax bill, the biggest overhaul of the U.S. tax code in three decades…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:congressional approvalObamacareObamacare repealRepublican tax overhaulRepublican U.S. tax bill

Legislative Successes in 2017: Rheumatologists lead the push in Congress for access to care, research funding, transparency in drug pricing

Larry Beresford  |  December 20, 2017

SAN DIEGO—The 2017 ACR/ARHP Annual Meeting, Nov. 3–8, presented opportunities to highlight its 2017 legislative advocacy victories, some of which were resolved just weeks before the conference began, as well as issues that are still outstanding. In the session, Legislative & Regulatory Update 2017, Angus Worthing, MD, chair of the ACR’s Government Advocacy Committee and…

Filed under:Legislation & Advocacy Tagged with:Cap on rehab therapyH-1B visasIndependent Payment Advisory Board (IPAB)NIH research fundingpharmacy benefit managers (PBMs)

Rheumatology Coding Corner Answers: 2017 End-of-Year Quiz

From the College  |  December 19, 2017

Take the challenge. 1. B—No. CPT 99358, prolonged evaluation and management service can be billed before or after direct patient care, first hour or 99539 —each additional 30 minutes (list separately in addition to code for prolonged service). This code cannot be used to bill a higher level E/M visit code. According to 2017 CPT:…

Filed under:Billing/CodingFrom the CollegePractice Support Tagged with:AuditsBillingCodingdenosumabDocumentationinfliximabInfusionMedical decision makingpatient carephysicianrheumatologistrheumatologyZone Program Integrity Contractor

Long-Term Benefits, Risks of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with RA

Nan Yang, PharmD, & Kurt Oelke, MD, on behalf of the ARHP Practice Committee  |  December 19, 2017

Two decades have passed since the first biologic disease-modifying anti-rheumatic drug (bDMARD) was approved. Studies on the long-term use of biologics in different disease states, such as for cardiovascular disease (CVD) and malignancy, as well as for knee/hip replacement, reveal some encouraging news. In clinical trials, bDMARDs have been shown to increase the risk of…

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Association of Rheumatology Professionals (ARP)bDMARDbenefitsbiologic disease-modifying antirheumatic drugsCardiovascular diseaseClinicalhipkneeoutcomepatient carereplacementResearchRheumatoid arthritisrheumatologistrheumatologyriskstudytherapy

Fellows’ Forum Case Report: Progressive Weakness and Debilitation with Skin Rash

Usman T. Malik, MBBS  |  December 19, 2017

The Presentation A pale, quiet woman—her mother—wheeled the girl into my clinic. It was a blistering Florida day, and the girl was shivering. She glanced up at me when I said hello and asked her name. “Hi,” she said, giving me a broad smile. Her smile was the only broad thing about her. Her elbows…

Filed under:ConditionsMyositisOther Rheumatic Conditions Tagged with:amyopathyAutoimmune diseaseClinicaldermatomyositisDiagnosisfellowFellowsFellows Foruminflammatory myopathymuscle weaknessoutcomepatient carepolymyopathyRheumatic DiseaserheumatologistrheumatologysymptomTestTreatment

Key Findings in Basic Science This Year Hold Promise for Potential Rheumatology Therapies

Thomas R. Collins  |  December 18, 2017

SAN DIEGO—After sifting through the nitty-gritty of the rheumatic disease literature on basic science, Richard Pope, MD—professor of medicine specializing in rheumatology at Northwestern University Feinberg School of Medicine—underscored several findings he thought stood out from the pack in his Year in Review talk at the 2017 ACR/ARHP Annual Meeting. He reviewed findings from November…

Filed under:ConditionsMeeting ReportsResearch Rheum Tagged with:2017 ACR/ARHP Annual MeetingAC&RAdenosineAmerican College of Rheumatology (ACR)findingsmicemicrogliaNature CommunicationsOsteoarthritisResearchrheumatologistrheumatologysciencestudytherapy

Laurent/Yakou / Science Source

How to Recognize, Diagnose Periodic Fever Syndromes in Adults

Rick Brasington, MD  |  December 18, 2017

A number of autoinflammatory syndromes that result from genetic mutations have been described recently. The vast majority occur in children. However, three periodic fever syndromes are important for rheumatologists who treat adults to know about. The goal of this review is to provide a concise description of each condition, and to help the clinician understand…

Filed under:ConditionsOther Rheumatic ConditionsPediatric Conditions Tagged with:adult Still's DiseasearthralgiasArthritisASDautoinflammatoryClinicalDiagnosisFamilial Mediterranean feverfevergenetic mutationoutcomepatient carePediatricreceptor-associated periodic syndromerheumatologistrheumatologyTRAPSTreatment

Incoming ACR President Dr. David Daikh Considers Serving Organization an Honor and Privilege

David Daikh, MD, PhD  |  December 17, 2017

Following the 2017 ACR/ARHP Annual Meeting when the formal transition in volunteer leadership occurred, my overwhelming thought has been that it is an honor and privilege to serve you as the 81st president of the ACR. Honor stems from the heritage of excellence and progress that defines this organization. Privilege comes from the opportunity to…

Filed under:President's Perspective Tagged with:AC&RACR Rise RegistryAmerican College of Rheumatology (ACR)CareerDr. David DaikhEducationfuturegoalspatient carepresidentrheumatologistrheumatologyStrategyVolunteerism

A History of the Science, Treatment of Rheumatologic Illnesses from Gold to Gene Therapy

Simon M. Helfgott, MD  |  December 17, 2017

Mysterious Ways The juxtaposition of the old and the new was readily evident that busy Wednesday morning. My first patient, a 94-year-old gentleman, Hal, arrived with a precise request. His rheumatologist for the past 40 years had just retired, and he was searching for a doctor with expertise in the use of gold sodium aurothioglucose,…

Filed under:ConditionsOpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:American College of Rheumatology (ACR)American Rheumatism AssociationArthritisautoimmune mediated diseasebioinformaticsC-reactive proteinClinicalcorticosteroid drugsDiagnosisgenomicsHistoryimmune-suppressive therapiesinflammationknowledgemedicalpatient careResearchRheumatic Diseaserheumatologysciencetranslational researchTreatment

Kateryna Kon / Shutterstock.com

How to Manage, Treat Anemia of Inflammation in Patients with Rheumatic Disease

Ruth Jessen Hickman, MD  |  December 17, 2017

Anemia is common in patients with systemic rheumatic disease, yet it may not get the attention it deserves. Anemia can result from chronic inflammation, treatment side effects or other disease factors, or it may signal an unrelated condition. Although diagnosis and treatment of anemia are sometimes challenging, clinicians must do their utmost to rigorously investigate…

Filed under:Conditions Tagged with:anemiaCauseClinicalDiagnosisinflammationkidneymacrocytic anemiaManagementoutcomepathophysiologypatient careRheumatic Diseaserheumatologistrheumatologysystemic inflammatory syndromeTestTreatmentvitamin deficiency

  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 128
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences